51,775 cases of mucormycosis reported in India: Minister
December 03, 2021  17:36
image
A total of 51,775 cases of mucormycosis have been reported till November 29, Union Health Minister Mansukh Mandaviya informed the Lok Sabha on Friday. 

 On the steps taken by the government to tackle such cases, Mandaviya in written reply to a question said health is a state subject and the Union Ministry of Health has proactively supported states to tackle the challenge posed by cases of mucormycosis during the second surge of COVID-19.

 The ministry had asked all states to make mucormycosis a notifiable disease so as to get details of its prevalence in the country. A unified portal was created by the ministry for states to enter surveillance data of mucormycosis cases.

 The Ministry of Health has issued national comprehensive guidelines for the management of post-COVID-19 sequelae, including mucormycosis, he said in the written reply. 

 The clinical management guidelines for COVID-19 cases by the Ministry of Health advocates rational use of steroids for managing moderate to severe cases of COVID-19 under strict medical supervision, the minister said. 

 Further noting the relationship between use of steroids and other immune-suppressive drugs, the advisory for rational use of steroids and Tocilizumab in the treatment of COVID-19 patients was issued by the Directorate General of Health Services.
« Back to LIVE

TOP STORIES